US 9518096
Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
granted A61KA61K2039/5258A61K2039/543
Quick answer
US patent 9518096 (Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity) held by Takeda Vaccines, Inc. expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/5258, A61K2039/543, A61K2039/55505, A61K2039/55572